1IC
BIIB icon

1919 Investment Counsel’s Biogen BIIB Stock Holding History

1919 Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.13M Sell
3,414
-11
-0.3% -$3.63K 0.02% 372
2014
Q2 		$1.08M Sell
3,425
-1,189
-26% -$358K 0.02% 374
2014
Q1 		$1.41M Buy
4,614
+23
+0.5% +$7.3K 0.03% 344
2013
Q4 		$1.28M Sell
4,591
-1,056
-19% -$273K 0.03% 347
2013
Q3 		$1.36M Buy
5,647
+72
+1% +$16.1K 0.03% 340
2013
Q2 		$1.2M Buy
+5,575
New +$1.19M 0.03% 340

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

1919 Investment Counsel's BIIB Position: Q3 2014 in Review

1919 Investment Counsel reduced its Biogen (BIIB) stake by 0.32% in Q3 2014, selling an estimated $3.63K and leaving 3,414 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #372.

1919 Investment Counsel first reported a position in BIIB in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.41M in Q1 2014. 819 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

  • 1919 Investment Counsel held 3,414 shares of Biogen worth $1.13M as of Q3 2014.
  • 1919 Investment Counsel sold 11 Biogen shares in Q3 2014, an estimated $3.63K.
  • Biogen made up 0.02% of 1919 Investment Counsel's portfolio in Q3 2014, its #372 holding.
  • 1919 Investment Counsel first reported a position in Biogen in Q2 2013 and has held it in 6 quarters since.
  • 1919 Investment Counsel's Biogen position peaked at $1.41M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.